| Harvoni 45 mg/200 mg Film-coated tablet EU/1/14/958/003 |
Ledipasvir, Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Harvoni 90 mg/400 mg Film-coated tablet EU/1/14/958/001-002 |
Sofosbuvir, Ledipasvir |
Gilead Sciences Ireland UC |
— |
| HBVAXPRO EU/1/01/183/002 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/003 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/004 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/005 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/006 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/007 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/008 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/009 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/010 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/011 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/012 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/013 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/014 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/015 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
Marketed |
| HBVAXPRO EU/1/01/183/018-025 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/026-029 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO 5 micrograms, suspension for injection EU/1/01/183/001 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| Hefiya 20 mg solution for injection in pre-filled syringe EU/1/18/1287/007 |
Adalimumab |
Sandoz GmbH |
— |
| Hefiya 40 mg solution for injection in pre-filled pen EU/1/18/1287/004-006 |
Adalimumab |
Sandoz GmbH |
— |
| Hefiya 40 mg solution for injection in pre-filled syringe EU/1/18/1287/001-003 |
Adalimumab |
Sandoz GmbH |
— |
| Hefiya 80 mg solution for injection in pre-filled pen EU/1/18/1287/010-011 |
Adalimumab |
Sandoz GmbH |
— |
| Hefiya 80 mg solution for injection in pre-filled syringe EU/1/18/1287/008-009 |
Adalimumab |
Sandoz GmbH |
— |
| Helicobacter Test INFAI 75 mg powder for oral solution EU/1/97/045/001 |
13c-urea |
INFAI Institut fur biomedizinish |
— |
| Helicobacter Test INFAI for children of the age 3-11 EU/1/97/045/003 |
13c-urea |
INFAI Institut fur biomedizinish |
— |
| HEMANGIOL 3.75 mg/mL oral solution EU/1/14/919/001 |
Propranolol hydrochloride |
Pierre Fabre Dermatologie |
— |
| Hemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusion EU/1/22/1715/001 |
Etranacogene dezaparvovec |
CSL Behring GmbH |
— |
| Hemlibra 150 mg/mL solution for injection EU/1/18/1271/002-004 |
Emicizumab |
Roche Registration GmbH |
— |
| Hemlibra 30 mg/mL solution for injection EU/1/18/1271/001 |
Emicizumab |
Roche Registration GmbH |
— |
| HEPCLUDEX 2 mg powder for solution for injection EU/1/20/1446/001 |
Bulevirtide |
Gilead Sciences Ireland UC |
— |
| HEPLISAV B 20 micrograms solution for injection in pre-filled syringe EU/1/20/1503/001 |
Hepatitis b surface antigen |
Dynavax GmbH |
— |
| Herceptin 150 mg powder for concentrate for solution for infusion EU/1/00/145/001 |
Trastuzumab |
Roche Registration GmbH |
— |
| Herceptin 600 mg solution for injection in vial EU/1/00/145/002 |
Trastuzumab |
Roche Registration GmbH |
— |
| Herwenda 150 mg powder for concentrate for solution for infusion EU/1/23/1762/001 |
Trastuzumab |
Sandoz GmbH |
— |
| Herzuma 150 mg powder for concentrate for solution for infusion EU/1/17/1257/001 |
Trastuzumab |
Celltrion Healthcare Hungary Kft. |
— |
| Herzuma 420 mg powder for concentrate for solution for infusion EU/1/17/1257/002-003 |
Trastuzumab |
Celltrion Healthcare Hungary Kft. |
— |
| HETLIOZ 20 mg hard capsules EU/1/15/1008/001 |
Tasimelteon |
Vanda Pharmaceuticals Netherlands B.V. |
— |
| HETRONIFLY 10 mg/ml concentrate for solution for infusion EU/1/24/1870/001 |
Serplulimab |
Accord Healthcare S.L.U. |
— |
| Hexacima suspension for injection EU/1/13/828/001-007 |
Haemophilus influenzae type b capsular polysaccharide, Pertussis toxoid, (polyribosylribitol phosphate) conjugated to tetanous protein, Filamentous haemagglutinin, Type 1 (mahoney) |
Sanofi Winthrop Industrie |
— |
| Hexyon suspension for injection EU/1/13/829/001-007 |
(polyribosylribitol phosphate) conjugated to tetanous protein, Type 1 (mahoney), Haemophilus influenzae type b polysaccharide, Diphtheria toxoid, Type 2 (mef-1) |
Sanofi Winthrop Industrie |
— |
| Hidrasec 100 mg hard capsules PA1714/001/001 |
Racecadotril |
Bioproject Europe Ltd |
Not marketed |
| Hidrasec Children 30mg Granules for Oral Suspension PA1714/001/003 |
Racecadotril |
Bioproject Europe Ltd |
Not marketed |
| Hidrasec Infants 10mg Granules for Oral Suspension PA1714/001/002 |
Racecadotril |
Bioproject Europe Ltd |
Not marketed |
| Hirobriz Breezhaler 150 microgram inhalation powder, hard capsules EU/1/09/594/1-5 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Hirobriz Breezhaler 300 microgram inhalation powder, hard capsules EU/1/09/594/6-10 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Hizentra 200 mg/ml solution for subcutaneous injection EU/1/11/687/001-12 |
Human normal immunoglobulin |
CSL Behring GmbH |
— |
| Holoclar 79,000 - 316,000 cells/cm2 living tissue equivalent EU/1/14/987/001 |
Ex vivo expanded autologous corneal epithelial cells containing stem cells |
Holostem S.r.l. |
— |
| Hukyndra 20 mg solution for injection in pre-filled syringe EU/1/21/1589/010 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 40 mg solution for injection in pre-filled pen EU/1/21/1589/004-006 |
Adalimumab |
Stada Arzneimittel AG |
— |